141 related articles for article (PubMed ID: 26318959)
1. Visual functioning and health-related quality of life in diabetic patients about to undergo anti-vascular endothelial growth factor treatment for sight-threatening macular edema.
Granström T; Forsman H; Leksell J; Jani S; Raghib AM; Granstam E
J Diabetes Complications; 2015; 29(8):1183-90. PubMed ID: 26318959
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.
Mitchell P; Bressler N; Tolley K; Gallagher M; Petrillo J; Ferreira A; Wood R; Bandello F;
JAMA Ophthalmol; 2013 Oct; 131(10):1339-47. PubMed ID: 23974915
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema: Report From RESTORE, RIDE, and RISE Trials.
Bressler NM; Varma R; Mitchell P; Suñer IJ; Dolan C; Ward J; Ferreira A; Ehrlich JS; Turpcu A
JAMA Ophthalmol; 2016 Feb; 134(2):160-6. PubMed ID: 26584450
[TBL] [Abstract][Full Text] [Related]
4. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
[TBL] [Abstract][Full Text] [Related]
5. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes and visual acuity after 12months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting.
Granström T; Forsman H; Lindholm Olinder A; Gkretsis D; Eriksson JW; Granstam E; Leksell J
Diabetes Res Clin Pract; 2016 Nov; 121():157-165. PubMed ID: 27718374
[TBL] [Abstract][Full Text] [Related]
7. Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE.
Bressler NM; Varma R; Suñer IJ; Dolan CM; Ward J; Ehrlich JS; Colman S; Turpcu A;
Ophthalmology; 2014 Dec; 121(12):2461-72. PubMed ID: 25148789
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
Heier JS; Bressler NM; Avery RL; Bakri SJ; Boyer DS; Brown DM; Dugel PU; Freund KB; Glassman AR; Kim JE; Martin DF; Pollack JS; Regillo CD; Rosenfeld PJ; Schachat AP; Wells JA;
JAMA Ophthalmol; 2016 Jan; 134(1):95-9. PubMed ID: 26512939
[TBL] [Abstract][Full Text] [Related]
9. Changes in vision related quality of life in patients with diabetic macular edema: ranibizumab or laser treatment?
Turkoglu EB; Celık E; Aksoy N; Bursalı O; Ucak T; Alagoz G
J Diabetes Complications; 2015; 29(4):540-3. PubMed ID: 25817172
[TBL] [Abstract][Full Text] [Related]
10. [Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF].
Stéphan S; Fajnkuchen F; Addou-Regnard M; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2014 Nov; 37(9):717-21. PubMed ID: 25308789
[TBL] [Abstract][Full Text] [Related]
11. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
[TBL] [Abstract][Full Text] [Related]
12. Vision-related quality of life in patients with diabetic macular oedema.
Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
[TBL] [Abstract][Full Text] [Related]
13. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
[TBL] [Abstract][Full Text] [Related]
14. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.
Schmidt-Erfurth U; Lang GE; Holz FG; Schlingemann RO; Lanzetta P; Massin P; Gerstner O; Bouazza AS; Shen H; Osborne A; Mitchell P;
Ophthalmology; 2014 May; 121(5):1045-53. PubMed ID: 24491642
[TBL] [Abstract][Full Text] [Related]
15. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal aflibercept for diabetic macular edema.
Korobelnik JF; Do DV; Schmidt-Erfurth U; Boyer DS; Holz FG; Heier JS; Midena E; Kaiser PK; Terasaki H; Marcus DM; Nguyen QD; Jaffe GJ; Slakter JS; Simader C; Soo Y; Schmelter T; Yancopoulos GD; Stahl N; Vitti R; Berliner AJ; Zeitz O; Metzig C; Brown DM
Ophthalmology; 2014 Nov; 121(11):2247-54. PubMed ID: 25012934
[TBL] [Abstract][Full Text] [Related]
17. One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.
Do DV; Nguyen QD; Boyer D; Schmidt-Erfurth U; Brown DM; Vitti R; Berliner AJ; Gao B; Zeitz O; Ruckert R; Schmelter T; Sandbrink R; Heier JS;
Ophthalmology; 2012 Aug; 119(8):1658-65. PubMed ID: 22537617
[TBL] [Abstract][Full Text] [Related]
18. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
[TBL] [Abstract][Full Text] [Related]
19. Effect of macular ischemia on intravitreal ranibizumab treatment for diabetic macular edema.
Douvali M; Chatziralli IP; Theodossiadis PG; Chatzistefanou KI; Giannakaki E; Rouvas AA
Ophthalmologica; 2014; 232(3):136-43. PubMed ID: 25171753
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
Do DV; Nguyen QD; Vitti R; Berliner AJ; Gibson A; Saroj N; Soo Y; Boyer DS
Ophthalmology; 2016 Apr; 123(4):850-7. PubMed ID: 26832658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
